Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shan Cen

Showing results (221-230 of 264) with videos related to

Pageof 27
Sort By:
Plos Pathogens|October 12, 2022
SERINC5 restricts influenza virus infectivityFei Zhao, Fengwen Xu, Xiaoman Liu, et al.
Frontiers in Microbiology|December 19, 2022
A newly identified interaction between nucleolar NPM1/B23 and the HTLV-I basic leucine zipper factor in HTLV-1 infected cellsZhenlong Liu, Émilie Larocque, Yongli Xie, et al.
Viruses|November 24, 2022
IFITM3 Inhibits SARS-CoV-2 Infection and Is Associated with COVID-19 SusceptibilityFengwen Xu, Geng Wang, Fei Zhao, et al.
Molecular Therapy. Nucleic Acids|June 26, 2020
CRISPR-Cas13a Inhibits HIV-1 InfectionLijuan Yin, Fei Zhao, Hong Sun, et al.
European Journal of Medicinal Chemistry|May 9, 2025
Thiol esters as chemical warheads of SARS-CoV-2 main protease (3CLpro) peptide-like inhibitorsXuehong Qiao, Menghan Cui, Zhiwei Yu, et al.
The Biochemical Journal|January 9, 2019
MOV10 sequesters the RNP of influenza A virus in the cytoplasm and is antagonized by viral NS1 proteinJian Li, Siqi Hu, Fengwen Xu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 14, 2023
Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitorsLing Ma, Yali Li, Ting Shi, et al.
Antiviral Research|February 1, 2011
Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistanceYu-Ping Wang, Wei Zhao, Rong Xue, et al.
European Journal of Medicinal Chemistry|November 18, 2019
Design and synthesis of 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides as novel dual inhibitors of respiratory syncytial virus and influenza virus AGuo-Ning Zhang, Qiang Li, Jianyuan Zhao, et al.
Virology|July 16, 2019
High-throughput screening of active compounds against human respiratory syncytial virusYuan-Hui Fu, Zhu-Xin Xu, Nan Jiang, et al.
Pageof 27

Showing results (221-230 of 264) with videos related to

Sort By:
Pageof 27
Plos Pathogens|October 12, 2022
SERINC5 restricts influenza virus infectivityFei Zhao, Fengwen Xu, Xiaoman Liu, et al.
Frontiers in Microbiology|December 19, 2022
A newly identified interaction between nucleolar NPM1/B23 and the HTLV-I basic leucine zipper factor in HTLV-1 infected cellsZhenlong Liu, Émilie Larocque, Yongli Xie, et al.
Viruses|November 24, 2022
IFITM3 Inhibits SARS-CoV-2 Infection and Is Associated with COVID-19 SusceptibilityFengwen Xu, Geng Wang, Fei Zhao, et al.
Molecular Therapy. Nucleic Acids|June 26, 2020
CRISPR-Cas13a Inhibits HIV-1 InfectionLijuan Yin, Fei Zhao, Hong Sun, et al.
European Journal of Medicinal Chemistry|May 9, 2025
Thiol esters as chemical warheads of SARS-CoV-2 main protease (3CLpro) peptide-like inhibitorsXuehong Qiao, Menghan Cui, Zhiwei Yu, et al.
The Biochemical Journal|January 9, 2019
MOV10 sequesters the RNP of influenza A virus in the cytoplasm and is antagonized by viral NS1 proteinJian Li, Siqi Hu, Fengwen Xu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 14, 2023
Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitorsLing Ma, Yali Li, Ting Shi, et al.
Antiviral Research|February 1, 2011
Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistanceYu-Ping Wang, Wei Zhao, Rong Xue, et al.
European Journal of Medicinal Chemistry|November 18, 2019
Design and synthesis of 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides as novel dual inhibitors of respiratory syncytial virus and influenza virus AGuo-Ning Zhang, Qiang Li, Jianyuan Zhao, et al.
Virology|July 16, 2019
High-throughput screening of active compounds against human respiratory syncytial virusYuan-Hui Fu, Zhu-Xin Xu, Nan Jiang, et al.
Pageof 27